Ahmed Kalebi Ahmed Kalebi ConsultancyKenya

Dr Ahmed Kalebi MBChB (Nbi) MMed Path (Nbi) FC Path (SA) FCPath (ECSA) is a Consultant Pathologist in independent practice (at Ahmed Kalebi Consultancy), having been the Founder and Retired Managing Director/CEO of Lancet Group Laboratories in East Africa, which is one of the leading and largest independent private laboratories in the region [2009 - April 2021]. He took a 3-4 years career-break / sabbatical from corporate and clinical laboratory practice from April 2021, currently focusing on family, self-care, social justice projects and incubating future ventures. He is also pursuing a PhD in Public Health looking at Inequity in Laboratory Medicine at the University of Cape Town since January 2022.He undertook his undergraduate medical degree and postgraduate training in general pathology at the University of Nairobi.He had further fellowship training in Anatomical Pathology at the University of the Witwatersrand in Johannesburg South Africa 2006-2009, with elective fellowship training in renal pathology at the John Radcliffe Hospital in Oxford England in 2008 under Prof Ian Roberts, both through scholarship from the British Division of the International Academy of Pathology (IAP). He is a founding fellow and was the steering chairman of the College of Pathologists of East, Central and Southern Africa (COPECSA). He is also the current President of the East African Division of the International Academy of Pathology (EADIAP), in which he was the founding secretary in 2010.He has been an Honorary Lecturer at the University of Nairobi and has published over 20 articles in peer-reviewed journals, authored and contributed in several books related to pathology, as well as regularly participating in international conferences as an invited speaker and submitting abstracts. He previously served as the first pathologist in Garissa - North Eastern Province of Kenya. His areas of interest include renal pathology, dermatopathology, infectious disease pathology, surgical-oncology pathology and advocacy for improved diagnostic pathology in under-served regions. He has received numerous professional awards including ‘Young Achievers Award’ from the Association of Pathologists of East Central and Southern Africa (APECSA) in 2006, inclusion in the ‘Who is Who in the World’ since 2009 and the inaugural ‘Top 40 Under 40 Men’ from Business Daily newspaper in 2011. He was also selected in the Power List for three years in a row in 2019, 2020 and 2021 (prior to his career-break) by the Pathologist Magazine featuring top Trail-Blazers in Pathology and Laboratory Medicine.He was awarded the Presidential Order of the Grand Warrior (OGW) by the President of Kenya in December 2021 for his services rendered to the country and the international community.He is keen to foster improved accessibility, availability, affordability and acceptability of quality laboratory services across low and middle income countries (LMIC) with particular focus in renal pathology.www.ahmedkalebi.com

30 MARCH 2023

Time Session
14:00
16:00
Wesam Ismail Chairperson Egypt
Peter Boor Chairperson pboor@ukaachen.deRWTH Aachen UniversityGermany
Suxia Wang Chairperson Peking University First HospitalChina
  • Nephrologist, Clinical Discussant - Case 1
    Chagriya Kitiyakara Speaker Faculty of Medicine Ramathibodi HospitalThailand
  • Case 1
    Beom Jin Lim Speaker bjlim@yuhs.acYonsei University College of MedicineSouth Korea
  • Nephrologist, Clinical Discussant - Case 2
    Chagriya Kitiyakara Speaker Faculty of Medicine Ramathibodi HospitalThailand
  • Case 2
    Olga Vorobyeva Speaker olgavor1970@yahoo.comRussia
  • Nephrologist, Clinical Discussant - Case 3
    Chagriya Kitiyakara Speaker Faculty of Medicine Ramathibodi HospitalThailand
  • Case 3
    Ahmed Kalebi Speaker Ahmed Kalebi ConsultancyKenya
  • Nephrologist, Clinical Discussant - Case 4
    Chagriya Kitiyakara Speaker Faculty of Medicine Ramathibodi HospitalThailand
  • Case 4
    Geetika Singh Speaker All India Institute of Medical Sciences, New DelhiIndia
  • Nephrologist, Clinical Discussant - Case 5
    Chagriya Kitiyakara Speaker Faculty of Medicine Ramathibodi HospitalThailand
  • Case 5
    Boonyarit Cheunsuchon Speaker Siriraj hospital Mahidol universityThailand
  • Nephrologist, Clinical Discussant - Case 6
    Chagriya Kitiyakara Speaker Faculty of Medicine Ramathibodi HospitalThailand
  • Case 6
    Peter Boor Speaker pboor@ukaachen.deRWTH Aachen UniversityGermany
Plenary Hall 1

31 MARCH 2023

Time Session
17:00
18:00
  • Acute Kidney Injury – Mechanisms, Experimental Models and Biomarkers
    Letizia De Chiara Moderator letizia.dechiara@unifi.itUniversità degli studi di FirenzeItaly
  • Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 1
    Chirag Parikh Moderator chirag.parikh@jhmi.eduJohns Hopkins UniversityUnited States
  • Bioethics, Supportive/Palliative Care and Quality of Life in Kidney Failure
    Marques Ng Moderator The Chinese University of Hong KongHong Kong, China
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 1
    Chuan-Ming Hao Moderator Huashan Hospital Fudan UniversityChina
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 2
    Vivek Kumar Moderator PGIMER, ChandigarhIndia
  • Chronic Kidney Disease Diagnosis, Classification and Progression 1
    Sydney Tang Moderator The University of Hong KongHong Kong, China
  • Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 1
    Matthias Kretzler Moderator kretzler@umich.eduUniversity Of Michigan Medical CenterUnited States
  • Clinical Glomerulonephritis 1
  • Clinical Glomerulonephritis 2
    Warangkana Pichaiwong Moderator Rajavithi HospitalThailand
  • Covid-19 and AKI
    Neil Boudville Moderator Sir Charles Gairdner HospitalAustralia
  • Covid-19 and KF (Kidney Failure)
    Sarinya Boongird Moderator Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol UniversityThailand
  • Diabetic Kidney Disease, Drugs and Treatments 1
    John Cijiang He Moderator United States
  • Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 1
    Abduzhappar Gaipov Moderator Nazarbayev University School of MedicineKazakhstan
  • Epidemiology, Outcomes and Health Services Research in Dialysis 1
    Geraldo Bezerra da Silva Jr Moderator University of FortalezaBrazil
  • Experimental Models- Glomerulonephritis
  • Haemodialysis, Haemodiafiltration and Vascular Access 1
    Anil Agarwal Moderator akagarwalmd@gmail.comUniversity of California San Francisco at Fresno and VA Central California Health Care SystemUnited States
  • Kidney in Pregnancy and Post-Partum
    Liz Lightstone Moderator Imperial College London and Hammersmith HospitalUnited Kingdom
  • Kidney Transplantation and Transplant Immunology 1
    Eric Rondeau Moderator Sorbonne Université Hopital TenonFrance
  • Kidney Transplantation and Transplant Immunology 2
    Ahmed Kalebi Moderator Ahmed Kalebi ConsultancyKenya
  • Online Learning
    Amnart Chaiprasert Moderator Thailand
  • Other AKI
    Watanyu Parapiboon Moderator Maharat Nakhonratchasima HospitalThailand
  • Other CKD 1
    Juliana Chan Moderator The Chinese University of Hong KongHong Kong, China
  • Peritoneal Dialysis 1
    Xueqing Yu Moderator Guangdong Provincial People's HospitalChina
  • Social Media
    Sibel Bek Moderator Kocaeli University HospitalTurkey
  • Special Challenges in the Burden and Management of CKD in Developing Countries
    Kearkiat Praditpornsilpa Moderator kearkiat@hotmail.comThailand
Ballroom 2-3-4-Exhibition Hall